BIOSTATE human coagulation factor VIII 1000IU/ von Willebrand factor 2400IU powder for injection vial with diluent vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

biostate human coagulation factor viii 1000iu/ von willebrand factor 2400iu powder for injection vial with diluent vial

csl behring australia pty ltd - factor viii, quantity: 1000 iu; von willebrand factor, quantity: 2400 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.

BIOSTATE human coagulation factor VIII 500IU/ von Willebrand factor 1200IU powder for injection vial with diluent vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

biostate human coagulation factor viii 500iu/ von willebrand factor 1200iu powder for injection vial with diluent vial

csl behring australia pty ltd - von willebrand factor, quantity: 1200 iu; factor viii, quantity: 500 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.

BIOSTATE human coagulation factor VIII 500IU / von Willebrand Factor 1200IU powder for injection vial with diluent vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

biostate human coagulation factor viii 500iu / von willebrand factor 1200iu powder for injection vial with diluent vial

csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1200 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.